✦ LIBER ✦

Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma

✍ Scribed by Kai Ge; Farooq Minhas; James Duhadaway; Nien-Chen Mao; Darren Wilson; Roberto Buccafusca; Daitoku Sakamuro; Peter Nelson; S. Bruce Malkowicz; John Tomaszewski; George C. Prendergast

Publisher: John Wiley and Sons
Year: 2000
Tongue: French
Weight: 528 KB
Volume: 86
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(20000415)86:2<155::aid-ijc2>3.0.co;2-m

No coin nor oath required. For personal study only.

✦ Synopsis

The genetic events underlying the development of prostate cancer are poorly defined. c-Myc is often activated in tumors that have progressed to metastatic status, so events that promote this process may be important. Bin1 is a nucleocytoplasmic adaptor protein with features of a tumor suppressor that was identified through its ability to interact with and inhibit malignant transformation by c-Myc. We investigated a role for Bin1 loss or inactivation in prostate cancer because the human Bin1 gene is located at chromosome 2q14 within a region that is frequently deleted in metastatic prostate cancer but where no tumor suppressor candidate has been located. A novel polymorphic microsatellite marker located within intron 5 of the human Bin1 gene was used to demonstrate loss of heterozygosity and coding alteration in 40% of informative cases of prostate neoplasia examined. RNA and immunohistochemical analyses indicated that Bin1 was expressed in most primary tumors, even at slightly elevated levels relative to benign tissues, but that it was frequently missing or inactivated by aberrant splicing in metastatic tumors and androgen-independent tumor cell lines. Ectopic expression of Bin1 suppressed the growth of prostate cancer lines in vitro. Our findings support the candidacy of Bin1 as the chromosome 2q prostate tumor suppressor gene.

📜 SIMILAR VOLUMES

Relationship between loss of heterozygos

Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma

✍ Zhe Piao; Hoguen Kim; Bong Kyun Jeon; Woo Jung Lee; Chanil Park 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

## Background: Hepatocellular carcinoma (hcc) is one of the most common human tumors in asia and africa. the molecular genetic changes involving both protooncogenes and tumor suppressor genes are known to be involved in hepatocarcinogenesis, but the roles of the known tumor suppressor genes in hepa

Losses of the tumor suppressor BIN1 in b

Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity

✍ Kai Ge; James Duhadaway; Daitoku Sakamuro; Robert Wechsler-Reya; Carol Reynolds; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 326 KB 👁 1 views

Oncogenic activation of MYC occurs often in breast carcinoma and is associated with poor prognosis. Loss or inactivation of mechanisms that restrain MYC may therefore be involved in tumor progression. In this study, we show that the MYC-interacting adaptor protein BIN1 is frequently missing in malig

Loss of heterozygosity on chromosomes 10

Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma

✍ Ittmann, Michael M. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

Loss of heterozygosity (LOH) at chromosomal loci has been associated with the presence of tumor suppressor genes at the deleted loci. Twenty-six clinically localized, Stage B prostate carcinomas were analyzed for LOH on chromosomes 10 and 17 using microsatellite markers. Two of 26 carcinomas showed

Hypermethylation of the tumor suppressor

Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers

✍ Mei Y. Yu; Joanna H.M. Tong; Paul K.S. Chan; Tin L. Lee; Michael W.Y. Chan; Anth 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 162 KB 👁 1 views

## Abstract Loss of heterozygosity (LOH) at chromosome 3p21 is frequent in cervical cancers. The candidate tumor suppressor gene, __RASSF1A__ located at 3p21.3, is found to be inactivated in several major human cancers, implicating its significance in carcinogenesis. We aimed to investigate the sta

Functional inactivation of the KLF6 tumo

Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma

✍ Olga Camacho-Vanegas; Goutham Narla; Miriam S. Teixeira; Analisa DiFeo; Anjan Mi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 196 KB 👁 1 views

## Abstract Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor and possesses a high incidence of 10p loss. The KLF6 (Kruppel‐like transcription factor) tumor suppressor gene on 10p15 is inactivated by loss of heterozygosity (LOH) and/or somatic mutation in a number

Loss of heterozygosity studies indicate

Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncocytomas

✍ Catherine A. Thrash-Bingham; Hernando Salazar; Richard E. Greenberg; Kenneth D. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB 👁 2 views

We carried out a complete genome scan for loss of heterozygosity (LOH) in four renal oncocytomas by using highly polymorphic CA repeat microsatellite loci. Three of the four tumors exhibited LOH for chromosome arm I p, and the oncocytomas of both female patients lost Xq. Therefore, these chromosome